The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets. (Q38246712)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25196558%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

review article

1 reference

title

The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25196558%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

main subject

hepatocellular carcinoma

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25196558%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Ulrike Protzer

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25196558%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Tracy O'Connor

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25196558%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Mathias Heikenwalder

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25196558%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

language of work or name

English

0 references

publication date

1 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25196558%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25196558%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

235

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25196558%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

355-367

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25196558%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25196558%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of viral hepatitis and hepatocellular carcinoma

16 February 2020

cites work

1 reference

The global health burden of infection-associated cancers in the year 2002

21 January 2018

1 reference

Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development

21 January 2018

1 reference

Natural history of chronic hepatitis B REVEALed

21 January 2018

1 reference

Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma

21 January 2018

1 reference

Risk stratification for hepatitis B virus related hepatocellular carcinoma

21 January 2018

1 reference

Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.

21 January 2018

1 reference

The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma

21 January 2018

1 reference

Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis

21 January 2018

1 reference

Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus

21 January 2018

1 reference

Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor

21 January 2018

1 reference

Living in the liver: hepatic infections

21 January 2018

1 reference

Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks

21 January 2018

1 reference

The size of the viral inoculum contributes to the outcome of hepatitis B virus infection

21 January 2018

1 reference

Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity

21 January 2018

1 reference

The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions

21 January 2018

1 reference

Strategies to prevent and control hepatitis B and C virus infections: a global perspective

21 January 2018

1 reference

Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels

21 January 2018

1 reference

Control of hepatitis B virus at the level of transcription.

21 January 2018

1 reference

Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.

21 January 2018

1 reference

Immunology of hepatitis B virus and hepatitis C virus infection

21 January 2018

1 reference

Hepatitis B virus biology

21 January 2018

1 reference

Hepatitis B virus PreS/S gene variants: pathobiology and clinical implications

21 January 2018

1 reference

Hepatitis B virus morphogenesis

21 January 2018

1 reference

Hepatitis B viruses: reverse transcription a different way.

21 January 2018

1 reference

Immune escape by hepatitis B viruses.

21 January 2018

1 reference

Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice

21 January 2018

1 reference

Immunobiology and pathogenesis of viral hepatitis

21 January 2018

1 reference

Immune pathogenesis of hepatocellular carcinoma.

21 January 2018

1 reference

Hepatitis B virus infection--natural history and clinical consequences

21 January 2018

1 reference

Immune control of hepatitis B virus.

21 January 2018

1 reference

Regulatory T cells in viral hepatitis

21 January 2018

1 reference

T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies.

21 January 2018

1 reference

Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection.

21 January 2018

1 reference

Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection

21 January 2018

1 reference

Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice

21 January 2018

1 reference

The NF-κB subunit RelA/p65 is dispensable for successful liver regeneration after partial hepatectomy in mice

21 January 2018

1 reference

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

21 January 2018

1 reference

Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors

21 January 2018

1 reference

21 January 2018

Hepatocellular carcinoma

1 reference

Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.

21 January 2018

1 reference

Hepatocyte-specific deletion of the antiapoptotic protein myeloid cell leukemia-1 triggers proliferation and hepatocarcinogenesis in mice

21 January 2018

1 reference

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

21 January 2018

1 reference

A lymphotoxin-driven pathway to hepatocellular carcinoma

21 January 2018

1 reference

Mouse models of hepatocellular carcinoma

21 January 2018

1 reference

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

21 January 2018

1 reference

Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.

21 January 2018

1 reference

Prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.

21 January 2018

1 reference

Chronic hepatitis B: update 2009

21 January 2018

1 reference

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

21 January 2018

1 reference

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

21 January 2018

1 reference

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update

21 January 2018

1 reference

Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease

21 January 2018

1 reference

Aktualisierung der S 3-Leitlinie zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion

21 January 2018

1 reference

Quantitative Levels of Hepatitis B Virus DNA and Surface Antigen and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Receiving Long-Term Nucleos(t)ide Analogue Therapy

21 January 2018

1 reference

Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads

21 January 2018

1 reference

Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma

21 January 2018

1 reference

Virology. Response to Comment on "Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA".

21 January 2018

1 reference

Is there any value to hepatitis B virus genotype analysis?

21 January 2018

1 reference

The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B

21 January 2018

1 reference

Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma

21 January 2018

1 reference

Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens

21 January 2018

1 reference

Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis

21 January 2018

1 reference

Hepatitis B virus induced hepatocellular carcinoma

21 January 2018

1 reference

Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).

21 January 2018

1 reference

Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms

21 January 2018

1 reference

Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas

21 January 2018

1 reference

Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene.

21 January 2018

1 reference

The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients.

21 January 2018

1 reference

Re-evaluation of the carcinogenic significance of hepatitis B virus integration in hepatocarcinogenesis

21 January 2018

1 reference

LINE(1)s of evidence in HBV-driven liver cancer

21 January 2018

1 reference

Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach

21 January 2018

1 reference

ViralFusionSeq: accurately discover viral integration events and reconstruct fusion transcripts at single-base resolution

21 January 2018

1 reference

Viral-human chimeric transcript predisposes risk to liver cancer development and progression.

21 January 2018

1 reference

Ground glass hepatocytes contain pre-S mutants and represent preneoplastic lesions in chronic hepatitis B virus infection.

21 January 2018

1 reference

Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress

21 January 2018

1 reference

Gene expression analysis in HBV transgenic mouse liver: a model to study early events related to hepatocarcinogenesis

21 January 2018

1 reference

Transgenic expression of entire hepatitis B virus in mice induces hepatocarcinogenesis independent of chronic liver injury

21 January 2018

1 reference

The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound

21 January 2018

1 reference

Hepatitis B viral resistance: mechanisms and diagnosis

21 January 2018

1 reference

The hepatitis B virus and common mutants

21 January 2018

1 reference

Signal integration in the endoplasmic reticulum unfolded protein response

21 January 2018

1 reference

Integrated endoplasmic reticulum stress responses in cancer

21 January 2018

1 reference

Oxidative stress and cancer: an overview

21 January 2018

1 reference

Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma

21 January 2018

1 reference

Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-kappaB and pp38 mitogen-activated protein kinase

21 January 2018

1 reference

Molecular viral oncology of hepatocellular carcinoma

21 January 2018

1 reference

The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice

21 January 2018

1 reference

Hepatitis B virus pre-S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes.

21 January 2018

1 reference

Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis

21 January 2018

1 reference

The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator

21 January 2018

1 reference

The hepatitis B virus protein MHBs(t) sensitizes hepatoma cells to TRAIL-induced apoptosis through ERK2.

21 January 2018

1 reference

Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis

21 January 2018

1 reference

Occult hepatitis B virus and hepatocellular carcinoma

21 January 2018

1 reference

The hepatitis B virus X protein promotes hepatocellular carcinoma metastasis by upregulation of matrix metalloproteinases

21 January 2018

1 reference

HBx gene of hepatitis B virus induces liver cancer in transgenic mice

21 January 2018

1 reference

Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein

21 January 2018

1 reference

The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice

21 January 2018

1 reference

Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene

21 January 2018

1 reference

Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma

21 January 2018

1 reference

The conserved amino-terminal region (amino acids 1-20) of the hepatitis B virus X protein shows a transrepression function

21 January 2018

1 reference

Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection.

21 January 2018

1 reference

Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma

21 January 2018

1 reference

Expression of hepatitis B virus X protein is closely correlated with the high periportal inflammatory activity of liver diseases

21 January 2018

1 reference

Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis

21 January 2018

1 reference

Mechanisms of HBV-related hepatocarcinogenesis

21 January 2018

1 reference

Stimulation of cellular proliferation by hepatitis B virus X protein

21 January 2018

1 reference

Hepatitis B virus HBx protein activation of cyclin A-cyclin-dependent kinase 2 complexes and G1 transit via a Src kinase pathway

21 January 2018

1 reference

Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis

21 January 2018

1 reference

Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha

21 January 2018

1 reference

Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway

21 January 2018

1 reference

Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3

21 January 2018

1 reference

Altered binding site selection of p53 transcription cassettes by hepatitis B virus X protein

21 January 2018

1 reference

Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade

21 January 2018

1 reference

Hepatitis B virus X protein differentially activates RAS-RAF-MAPK and JNK pathways in X-transforming versus non-transforming AML12 hepatocytes

21 January 2018

1 reference

The senescent side of tumor suppression.

21 January 2018

1 reference

Hepatitis B virus X protein overcomes all-trans retinoic acid-induced cellular senescence by downregulating levels of p16 and p21 via DNA methylation

21 January 2018

1 reference

Hepatitis B virus X protein differentially regulates cell cycle progression in X-transforming versus nontransforming hepatocyte (AML12) cell lines

21 January 2018

1 reference

Role of miR-148a in hepatitis B associated hepatocellular carcinoma.

21 January 2018

1 reference

Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma

21 January 2018

1 reference

Ground-glass hepatocytes co-expressing hepatitis B virus X protein and surface antigens exhibit enhanced oncogenic effects and tumorigenesis.

21 January 2018

1 reference

Hepatitis B virus HBx protein localizes to mitochondria in primary rat hepatocytes and modulates mitochondrial membrane potential

21 January 2018

1 reference

The hepatitis B virus X protein elevates cytosolic calcium signals by modulating mitochondrial calcium uptake

21 January 2018

1 reference

Calcium signaling by HBx protein in hepatitis B virus DNA replication

21 January 2018

1 reference

Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1alpha through activation of mitogen-activated protein kinase pathway

21 January 2018

1 reference

HBx mutants differentially affect the activation of hypoxia-inducible factor-1α in hepatocellular carcinoma.

21 January 2018

1 reference

Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells

21 January 2018

1 reference

Molecular targeted therapies in hepatocellular carcinoma

21 January 2018

1 reference

Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer.

21 January 2018

1 reference

Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators

21 January 2018

1 reference

Increased expression of ErbB-2 in liver is associated with hepatitis B x antigen and shorter survival in patients with liver cancer

21 January 2018

1 reference

Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma

21 January 2018

1 reference

WNT and beta-catenin signalling: diseases and therapies

21 January 2018

1 reference

Association of the APC gene product with beta-catenin

21 January 2018

1 reference

Wnt/beta-catenin signaling in development and disease

21 January 2018

1 reference

Liver cancer in 2013: Mutational landscape of HCC--the end of the beginning.

21 January 2018

1 reference

Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma

21 January 2018

1 reference

Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1.

21 January 2018

1 reference

The hepatitis B virus HBx protein induces adherens junction disruption in a src-dependent manner.

21 January 2018

1 reference

The hepatitis B virus X protein (HBx) induces a migratory phenotype in a CD44-dependent manner: possible role of HBx in invasion and metastasis.

21 January 2018

1 reference

Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras

21 January 2018

1 reference

The mitogenic function of hepatitis B virus X protein resides within amino acids 51 to 140 and is modulated by N- and C-terminal regulatory regions

21 January 2018

1 reference

C-terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by C-Jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma.

21 January 2018

1 reference

Impact of hepatitis B virus (HBV) x gene mutations on hepatocellular carcinoma development in chronic HBV infection

21 January 2018

1 reference

Analysis of hepatitis B virus X gene (HBx) mutants in tissues of patients suffered from hepatocellular carcinoma in China.

21 January 2018

1 reference

X protein mutations in hepatitis B virus DNA predict postoperative survival in hepatocellular carcinoma

21 January 2018

1 reference

The enigmatic X gene of hepatitis B virus

21 January 2018

1 reference

Medical therapies for hepatocellular carcinoma: a critical view of the evidence

21 January 2018

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells.

21 January 2018

1 reference

Hepatocellular carcinoma: reasons for phase III failure and novel perspectives on trial design

21 January 2018

1 reference

Lessons from hereditary colorectal cancer

21 January 2018

1 reference

Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

21 January 2018

1 reference

Effects of Maternal Screening and Universal Immunization to Prevent Mother-to-Infant Transmission of HBV

21 January 2018

1 reference

Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach

21 January 2018

1 reference

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PATH.4434

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25196558%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference